| abstract |
The invention relates to a solid pharmaceutical oral dosage form in the form of a tablet, comprising febuxostat as the active substance, and a dry binder. To prepare such a dosage form which is characterised by proportionally low values of friability and is correspondingly easy to film-coat, the dry binder should have a D10 value of 1 μm to 15 μm, a D50 value of 10 μτη to 50 μτη and a D90 value of 30 μm to120 μτα. |